Aurinia Pharmaceuticals Inc.
AUPH
$8.18
$0.080.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.43M | 14.35M | 722.00K | -10.75M | -26.88M |
| Total Depreciation and Amortization | 4.86M | 4.89M | 4.84M | 4.85M | 4.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.34M | 9.84M | 4.50M | -1.94M | 16.81M |
| Change in Net Operating Assets | 22.48M | -12.05M | 5.78M | -10.76M | 19.43M |
| Cash from Operations | 30.11M | 17.03M | 15.84M | -18.60M | 14.31M |
| Capital Expenditure | -281.00K | -- | -- | -- | -299.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.50M | -10.57M | -38.62M | 49.23M | -5.96M |
| Cash from Investing | 39.22M | -10.57M | -38.62M | 49.23M | -6.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.03M | -2.96M | -3.22M | -2.78M | -6.54M |
| Issuance of Common Stock | 7.92M | 236.00K | 1.08M | 28.00K | 3.25M |
| Repurchase of Common Stock | -27.94M | 0.00 | -6.13M | -12.30M | -2.28M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.05M | -2.72M | -8.27M | -15.05M | -5.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.29M | 3.74M | -31.05M | 15.58M | 2.48M |